» Articles » PMID: 30217825

Human T-cell Leukemia Virus Type 1 Gag Domains Have Distinct RNA-binding Specificities with Implications for RNA Packaging and Dimerization

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Sep 16
PMID 30217825
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the first retrovirus that has conclusively been shown to cause human diseases. In HIV-1, specific interactions between the nucleocapsid (NC) domain of the Gag protein and genomic RNA (gRNA) mediate gRNA dimerization and selective packaging; however, the mechanism for gRNA packaging in HTLV-1, a deltaretrovirus, is unclear. In other deltaretroviruses, the matrix (MA) and NC domains of Gag are both involved in gRNA packaging, but MA binds nucleic acids with higher affinity and has more robust chaperone activity, suggesting that this domain may play a primary role. Here, we show that the MA domain of HTLV-1, but not the NC domain, binds short hairpin RNAs derived from the putative gRNA packaging signal. RNA probing of the HTLV-1 5' leader and cross-linking studies revealed that the primer-binding site and a region within the putative packaging signal form stable hairpins that interact with MA. In addition to a previously identified palindromic dimerization initiation site (DIS), we identified a new DIS in HTLV-1 gRNA and found that both palindromic sequences bind specifically the NC domain. Surprisingly, a mutant partially defective in dimer formation exhibited a significant increase in RNA packaging into HTLV-1-like particles, suggesting that efficient RNA dimerization may not be strictly required for RNA packaging in HTLV-1. Moreover, the lifecycle of HTLV-1 and other deltaretroviruses may be characterized by NC and MA functions that are distinct from those of the corresponding HIV-1 proteins, but together provide the functions required for viral replication.

Citing Articles

The Assembly of HTLV-1-How Does It Differ from HIV-1?.

Herrmann D, Meng S, Yang H, Mansky L, Saad J Viruses. 2024; 16(10).

PMID: 39459862 PMC: 11512237. DOI: 10.3390/v16101528.


Human T-cell leukemia virus type 1 uses a specific tRNA isodecoder to prime reverse transcription.

Syu Y, Hatterschide J, Budding C, Tang Y, Musier-Forsyth K RNA. 2024; 30(8):967-976.

PMID: 38684316 PMC: 11251516. DOI: 10.1261/rna.080006.124.


Identification of a putative Gag binding site critical for feline immunodeficiency virus genomic RNA packaging.

Krishnan A, Ali L, Prabhu S, Pillai V, Chameettachal A, Vivet-Boudou V RNA. 2023; 30(1):68-88.

PMID: 37914398 PMC: 10726167. DOI: 10.1261/rna.079840.123.


Molecular Biology and Diversification of Human Retroviruses.

Meissner M, Talledge N, Mansky L Front Virol. 2022; 2.

PMID: 35783361 PMC: 9242851. DOI: 10.3389/fviro.2022.872599.


Human Retrovirus Genomic RNA Packaging.

Hanson H, Willkomm N, Yang H, Mansky L Viruses. 2022; 14(5).

PMID: 35632835 PMC: 9142903. DOI: 10.3390/v14051094.


References
1.
Kurg A, Sommer G, Metspalu A . An RNA stem-loop structure involved in the packaging of bovine leukemia virus genomic RNA in vivo. Virology. 1995; 211(2):434-42. DOI: 10.1006/viro.1995.1425. View

2.
Moore M, Hu W . HIV-1 RNA dimerization: It takes two to tango. AIDS Rev. 2009; 11(2):91-102. PMC: 3056336. View

3.
Pachulska-Wieczorek K, Blaszczyk L, Biesiada M, Adamiak R, Purzycka K . The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag. Retrovirology. 2016; 13:18. PMC: 4794849. DOI: 10.1186/s12977-016-0245-1. View

4.
Purohit P, Dupont S, Stevenson M, Green M . Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA. 2001; 7(4):576-84. PMC: 1370111. DOI: 10.1017/s1355838201002023. View

5.
Qualley D, Stewart-Maynard K, Wang F, Mitra M, Gorelick R, Rouzina I . C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism. J Biol Chem. 2009; 285(1):295-307. PMC: 2804176. DOI: 10.1074/jbc.M109.051334. View